What Are Prednisone Side Effects in PG and How Is It Tapered?
At a Glance
Prednisone can calm pyoderma gangrenosum but may cause infections, blood sugar and mood changes, stomach problems, and bone loss. After longer or higher-dose use, it must be reduced on an individualized schedule because stopping suddenly can cause a dangerous lack of cortisol.
In this answer
4 sections
Prednisone is a systemic corticosteroid that can quickly reduce the severe inflammation of pyoderma gangrenosum (PG), but it carries risks of short- and long-term side effects. While some short courses of prednisone may be stopped easily, prolonged or high-dose courses change how your body naturally produces stress hormones and require a careful “taper” (slow dose reduction) to prevent life-threatening complications [1][2].
It is important to remember that not everyone experiences every side effect, and controlling your painful ulcers is a priority. Your care team will work with you to manage these risks and decide on the safest treatment path.
Potential Side Effects and When to Seek Help
Prednisone can cause a variety of side effects. Knowing what to watch for helps you understand when to contact your doctor and when to seek emergency care.
Infection Risk
Prednisone suppresses your immune system, which helps calm your PG but makes you more vulnerable to infections [1][3]. Because steroids can hide normal signs of infection (like blunting a fever), you must be extra vigilant [1].
- Action: Call your doctor promptly or seek emergency care if you develop fever, chills, a new cough, shortness of breath, urinary symptoms, or rapidly worsening redness, warmth, pain, or drainage around your ulcer. Do not try to self-diagnose whether your ulcer is infected or just flaring.
Blood Sugar, Blood Pressure, and Fluid Retention
Prednisone can cause high blood sugar—even in people who have never had diabetes [4]. It can also lead to high blood pressure, fluid retention, and weight gain [5]. Your doctor should regularly monitor your blood pressure and glucose levels [4].
- Action: Call your doctor if you experience extreme thirst, frequent urination, major swelling in your legs, or unexplained breathlessness.
Mood and Sleep Changes
Steroids can significantly affect your mental health. You may experience insomnia, anxiety, depression, or hypomania (feeling unusually energized, having racing thoughts, engaging in impulsive behavior, or needing very little sleep) [6][7].
- Action: Seek urgent medical help if you experience hallucinations (psychosis), severe agitation, unsafe behavior, or suicidal thoughts [8][7].
Stomach Problems
Prednisone increases the risk of gastrointestinal issues like heartburn or stomach ulcers [9]. The risk is highest if you are 65 or older, have a history of ulcers, or take nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen [9]. Your doctor may suggest a stomach-protecting medication if you are at high risk, but it is not automatically required for everyone [10].
- Action: Go to the emergency room immediately if you vomit blood or have black, tarry stools, as these can be signs of severe bleeding.
Bone and Eye Health
Long-term use can lead to osteoporosis (thinning of the bones) and increase your risk of cataracts or glaucoma (raised eye pressure) [11][12]. Report any new vision changes to your doctor.
Planning for Bones and Vaccinations
- Bone Protection: If you expect to take a daily dose of prednisone (2.5 mg or more) for three months or longer, your doctor should evaluate your risk for bone fractures [13][14]. This threshold does not mean you automatically need medication; rather, it is a prompt for assessment (like a bone density scan) [15]. Your care plan may include weight-bearing exercise, fall prevention, calcium and vitamin D supplements, and specific medications like bisphosphonates (drugs that slow bone loss) [14][15].
- Vaccination Planning: Because prednisone weakens your immune system, plan vaccinations carefully [3]. Non-live vaccines are generally safe, though they may be less effective while you are on steroids [3]. However, live vaccines are usually avoided if you are taking high doses of steroids (such as 20 mg or more per day for at least 14 days) due to the risk of severe infection [3][16]. Never get a vaccine without discussing the timing with your prescribing doctor first.
The Danger of Stopping Suddenly: Adrenal Suppression
When you take prednisone for an extended period, your brain senses the extra steroids in your system and stops telling your adrenal glands to produce cortisol, your body’s natural stress hormone [17][1]. This is called adrenal suppression.
If you stop taking prednisone abruptly, your body will not have enough cortisol to function normally or respond to physical stress (like an illness, injury, or surgery). This can trigger an adrenal crisis—a life-threatening medical emergency [18][19].
- Emergency Warning Signs: Go to the emergency room immediately if you experience fainting or collapse, severe dizziness, profound weakness, confusion, severe abdominal pain, persistent vomiting or diarrhea, or an inability to keep your prednisone pills down [18][19][20].
- Safety Planning: Ask your doctor for a “sick-day plan” (stress dosing) so you know how to adjust your dose if you become severely ill or need surgery. It is also highly recommended to carry a steroid emergency card or wear a medical-alert bracelet [21].
How Prednisone Is Tapered
To safely come off prolonged prednisone, your doctor will prescribe a tapering schedule. Tapering reduces the risk of withdrawal and adrenal crisis, though it does not guarantee your PG will not return [2][22].
- A Personalized Schedule: There is no single universal tapering schedule. Your plan depends on your prednisone dose and duration, previous steroid courses, recovery of your adrenal glands, and whether you have started a “steroid-sparing” medication to help control your PG long-term [2][23].
- The Tapering Process: Higher doses are generally reduced more quickly, but the taper slows down significantly as you approach “physiologic doses” (the normal amount of cortisol your body makes) [2]. The final stages can take months and may require morning blood tests to check your adrenal function [24][18].
- Withdrawal vs. Flare: As your dose decreases, you might experience fatigue, nausea, body aches, or dizziness. These can be signs of glucocorticoid withdrawal syndrome or adrenal insufficiency [25][18]. Alternatively, if your ulcers worsen, it could be a PG flare or an infection [22].
- Never Adjust Your Own Dose: Do not try to guess what your symptoms mean. Contact your care team promptly, and never change your dose on your own.
Common questions in this guide
What side effects should I watch for while taking prednisone for pyoderma gangrenosum?
Why is it dangerous to stop prednisone suddenly?
How long does a prednisone taper for pyoderma gangrenosum take?
What symptoms mean I need emergency help during a prednisone taper?
How can I tell prednisone withdrawal from a PG flare or infection?
Do I need special planning for bones and vaccines while taking prednisone?
Could another medicine reduce my need for prednisone?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Do I need a taper for this specific course of prednisone, and what is our plan if my ulcers worsen or I experience withdrawal symptoms as the dose decreases?
- 2.What specific warning signs of an adrenal crisis or severe infection mean I need to seek emergency medical care immediately?
- 3.Should we establish a "sick-day plan" in case I become ill, have surgery, or cannot keep my pills down, and should I carry a steroid emergency card?
- 4.Do my dose and medical history mean I need a fracture risk assessment, stomach protection, or regular monitoring of my blood pressure and blood sugar?
- 5.Is it time to discuss a "steroid-sparing" medication to control my pyoderma gangrenosum and reduce my long-term need for prednisone?
- 6.Which routine vaccines are safe and appropriate for me right now, and how should we time them around my prednisone treatment?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (25)
- 1
European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency.
Beuschlein F, Else T, Bancos I, et al.
European journal of endocrinology 2024; (190(5)):G25-G51 doi:10.1093/ejendo/lvae029.
PMID: 38714321 - 2
The Glucocorticoid Taper: A Primer for the Clinicians.
Priya G, Laway BA, Ayyagari M, et al.
Indian journal of endocrinology and metabolism 2024; (28(4)):350-362 doi:10.4103/ijem.ijem_410_23.
PMID: 39371659 - 3
Pulmonary Infections in Patients Receiving Corticosteroids and Other Immunomodulators.
Hartman ES, Cavallazzi R
Seminars in respiratory and critical care medicine 2026; (47(2)):215-227 doi:10.1055/a-2767-2557.
PMID: 41475423 - 4
Continuous Glucose Monitoring of Steroid-Induced Hyperglycemia in Patients With Dermatologic Diseases.
Kleinhans M, Albrecht LJ, Benson S, et al.
Journal of diabetes science and technology 2024; (18(4)):904-910 doi:10.1177/19322968221147937.
PMID: 36602041 - 5
Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review.
Rice JB, White AG, Scarpati LM, et al.
Clinical therapeutics 2017; (39(11)):2216-2229 doi:10.1016/j.clinthera.2017.09.011.
PMID: 29055500 - 6
Psychiatric Symptoms Associated with Corticosteroid Use: A Systematic Review and Meta-analysis.
Kusudo K, Mashima Y, Yasuda H, et al.
CNS drugs 2026; (40(8)):1101-1147 doi:10.1007/s40263-026-01298-5.
PMID: 42365562 - 7
Rate of Corticosteroid-Induced Mood Changes in Patients with Inflammatory Bowel Disease: A Prospective Study.
Ou G, Bressler B, Galorport C, et al.
Journal of the Canadian Association of Gastroenterology 2018; (1(3)):99-106 doi:10.1093/jcag/gwy023.
PMID: 31294728 - 8
Glucocorticoid-Induced Psychosis in Children and Adolescents: A Systematic Review.
Fani-Molky P, Bradley J, Cooper MS
Journal of child and adolescent psychopharmacology 2023; (33(3)):78-90 doi:10.1089/cap.2022.0077.
PMID: 37074331 - 9
Risk factors for gastrointestinal complications during glucocorticoid therapy in internal medicine inpatients: a real-world retrospective analysis.
Liu P, Li G, Yang Q, et al.
BMC pharmacology & toxicology 2025; (26(1)):37 doi:10.1186/s40360-025-00871-w.
PMID: 39979942 - 10
The Treatment of Giant Cell Arteritis.
Jivraj I, Tamhankar M
Current treatment options in neurology 2017; (19(1)):2 doi:10.1007/s11940-017-0440-y.
PMID: 28138903 - 11
Up-regulation of Ifi27l2a expression in bone marrow monocytes contributes to glucocorticoid-induced bone loss.
Wang Z, Huang C, Liu S, et al.
Communications biology 2025; (8(1)):1590 doi:10.1038/s42003-025-08985-x.
PMID: 41249558 - 12
Safe Use of Corticosteroids in Non-Infectious Uveitis.
Belletti M, Izquierdo-Escamez R, Tornero C, et al.
Journal of inflammation research 2025; (18()):14441-14455 doi:10.2147/JIR.S540821.
PMID: 41126968 - 13
Advances in treatment of glucocorticoid-induced osteoporosis.
Hsu E, Nanes M
Current opinion in endocrinology, diabetes, and obesity 2017; (24(6)):411-417 doi:10.1097/MED.0000000000000368.
PMID: 28857847 - 14
Glucocorticoid-induced osteoporosis: who to treat with what agent?
Rizzoli R, Biver E
Nature reviews. Rheumatology 2015; (11(2)):98-109 doi:10.1038/nrrheum.2014.188.
PMID: 25385412 - 15
Glucocorticoid-induced osteoporosis: 2019 concise clinical review.
Adami G, Saag KG
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2019; (30(6)):1145-1156 doi:10.1007/s00198-019-04906-x.
PMID: 30805679 - 16
Disseminated Cutaneous Herpes Zoster in a Patient with Uncontrolled Diabetes Mellitus.
Malkud S, Patil SM
Journal of clinical and diagnostic research : JCDR 2015; (9(7)):WD01-2 doi:10.7860/JCDR/2015/12242.6240.
PMID: 26393187 - 17
Treatment with Synthetic Glucocorticoids and the Hypothalamus-Pituitary-Adrenal Axis.
Paragliola RM, Papi G, Pontecorvi A, Corsello SM
International journal of molecular sciences 2017; (18(10)) doi:10.3390/ijms18102201.
PMID: 29053578 - 18
Adrenal Insufficiency in Adults: A Review.
Vaidya A, Findling J, Bancos I
JAMA 2025; (334(8)):714-725 doi:10.1001/jama.2025.5485.
PMID: 40522647 - 19
Adrenal crisis: prevention and management in adult patients.
Dineen R, Thompson CJ, Sherlock M
Therapeutic advances in endocrinology and metabolism 2019; (10()):2042018819848218 doi:10.1177/2042018819848218.
PMID: 31223468 - 20
Extensive expertise in endocrinology. Adrenal crisis.
Allolio B
European journal of endocrinology 2015; (172(3)):R115-24 doi:10.1530/EJE-14-0824.
PMID: 25288693 - 21
[Glucocorticoid-induced adrenal insufficiency].
Imamovic M, Dahlqvist P, Ragnarsson O, Einarsdottir M
Lakartidningen 2025; (122()).
PMID: 39935313 - 22
Real-world utilization of Delphi consensus diagnostic criteria for suspected pyoderma gangrenosum.
Ji-Xu A, Liakos W, Artounian K, et al.
Clinical and experimental dermatology 2022; (47(10)):1873-1875 doi:10.1111/ced.15298.
PMID: 35699684 - 23
Mycophenolate mofetil as adjunctive therapy to corticosteroids for the treatment of pyoderma gangrenosum: a case series and literature review.
Hrin ML, Bashyam AM, Huang WW, Feldman SR
International journal of dermatology 2021; (60(12)):e486-e492 doi:10.1111/ijd.15539.
PMID: 33739458 - 24
Glucocorticoid-induced adrenal insufficiency: physiological dose tapering promotes recovery.
Mehta R, Lazarus K, Sharma A, et al.
Endocrine connections 2026; (15(1)).
PMID: 41489002 - 25
Potential mechanisms of the glucocorticoid withdrawal syndrome.
Snyder CN, Frontera ED, Meng J, et al.
European journal of endocrinology 2026; (194(4)):R67-R81 doi:10.1093/ejendo/lvag062.
PMID: 41988948
This page is for informational purposes only and does not constitute medical advice about prednisone or pyoderma gangrenosum. Your prescribing clinician should set your taper and tell you when to seek urgent care.
Get notified when new evidence is published on Pyoderma gangrenosum.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.